Navigation Links
Bacterin to Present at 4th Annual LD MICRO Conference on December 8, 2011
Date:11/22/2011

BELGRADE, Mont., Nov. 22, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at LD MICRO's 4th Annual Conference on December 8, 2011. The conference will be held at the Luxe Hotel in Los Angeles.

Bacterin's chairman and CEO, Guy Cook, is scheduled to present on Thursday, December 8, 2011 at 10:30 a.m. Pacific time, with one-on-one meetings held throughout the day. Management will discuss Bacterin's recent quarterly results, as well as the company's business plan and objectives for the remainder of 2011.

Bacterin reported record revenue of $7.5 million in the third quarter 2011, up 80% year-over-year. For 2012, management expects revenue of $53 million to $56 million.

The LD MICRO Conference brings together 101 presenting companies with more than 150 institutions focused on investing in small and micro cap companies across multiple industries.

About LD MICRO

LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor. For more information on the list of presenting companies or to register for the event, please visit www.ldmicro.com or call +1-408-457-1042.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.bacterin.com.

Important Cautions Regarding Forward-looking Statements

This news release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability to obtain FDA concurrence use for anti-microbial coatings in a timely manner; the Company's ability to meet its obligations under existing and anticipated contractual obligations; the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results; the ability of the Company's customers to pay and the timeliness of such payments, particularly during recessionary periods; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Investor Relations:
Liolios Group, Inc.
Scott Liolios or Ron Both
Tel 949-574-3860
info@liolios.com


'/>"/>
SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin to Present at Sixth Annual Singular Research Best of the Uncovereds Conference on October 26, 2011
2. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
3. Bacterin International Sets Third Quarter 2011 Conference Call for Thursday, November 10, 2011 at 4:30 p.m. ET
4. Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 2011
5. Bacterin Second Quarter 2011 Revenues up 135% Over Prior Year, Driving First Positive EBITDA Quarter
6. Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
7. Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET
8. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
9. Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC
10. Bacterin International Holdings, Inc. Reports First Quarter 2011 Financial Results
11. Bacterin International Holdings Launches Third Biologic Scaffold
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... and PUNE, India , January ... published by Allied Market Research, titled, "Cold Chain Logistics ... Confectionary, Dairy & Frozen Dessert, Meat, Fish & Sea ... Analysis and Industry Forecasts, 2014-2022," projects that the global ... million by 2022, growing at a CAGR of 16% ...
(Date:1/24/2017)... , Jan. 24, 2017 Regeneron Pharmaceuticals, ... the Public today recognized 40 finalists in the Regeneron ... science and math competition for high school seniors. Finalists ... potential of their research projects. The finalists ... from March 9-15 to undergo a rigorous judging ...
(Date:1/24/2017)... -- Research and Markets has announced the addition of ... Material - Forecast to 2025" report to their offering. ... The Global Implantable ... around 5.4% over the next decade to reach approximately $54.28 billion ... market is witnessing include 3D medical printing is expected to develop ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... The Cradle to ... Agency (EPA) in its new recommendations of standards and ecolabels for ... announced. , Cradle to Cradle Certified is recommended at the highest level across ...
(Date:1/24/2017)... ... January 24, 2017 , ... In comments submitted ... (PCORI) for developing a data access and sharing policy. The nation’s leading biomedical ... plan as part of award applications, and earmarking specified amounts of grant funding ...
(Date:1/24/2017)... ... January 24, 2017 , ... i2i Population Health, a national leader in population ... , “Cary’s broad financial background is an excellent fit for i2i,” says Justin ... financial operations skills we need to take the company to the next level of ...
(Date:1/24/2017)... ... 24, 2017 , ... Seceon , the only threat ... today announced a strategic partnership with Paramount , the Middle East’s regional ... their critical information assets and infrastructure, in a comprehensive and cost effective manner. ...
(Date:1/24/2017)... ... 2017 , ... Center for Hispanic Leadership (CHL) Academy , the talent ... Manager, Employee & Labor Relations at City of Hope , a world-renowned independent ... Month. City of Hope is committed to stay out in front of its communities’ ...
Breaking Medicine News(10 mins):